Results 231 to 240 of about 137,025,890 (262)
Some of the next articles are maybe not open access.

[Acinetobacter baumannii bacteremia].

Revista medica del Instituto Mexicano del Seguro Social, 2011
Acinetobacter baumannii has emerged as an important nosocomial pathogen. It is difficult to control and treat. The most seriously ill patients and those previously infected are more likely than others to be infected or colonized by A. baumannii. The epidemiology of A.
Guadalupe, Aguirre-Avalos   +2 more
openaire   +1 more source

Beta laktamazių vaidmuo Acinetobacter baumannii (A. baumannii) atsparumo antibiotikams išsivykstymui

2019
Įvadas. Atsparumas antibiotikams yra didelė problema, kelianti susirūpinimą tiek ligoninių personalui, tiek kiekvienam visuomenės nariui. Nepaisant didėjančio antibiotikų atsparumo, A. baumannii lieka neaiškiai apibrėžtas beta laktamazių atsparumo mechanizmas. Darbo tikslas. Nustatyti iš klinikinės medžiagos išskirtų A.
Vaitkus, Žygimantas   +2 more
openaire   +1 more source

Acinetobacter baumannii Resistance: A Real Challenge for Clinicians

Antibiotics, 2020
Juan José Juárez Vignon-Whaley   +2 more
exaly  

Acinetobacter baumannii infections in children

The Lancet Infectious Diseases, 2010
Fernando Maria, de Benedictis   +2 more
openaire   +2 more sources

Semi-Synthetic Glycoconjugate Vaccine Lead Against Acinetobacter baumannii 17978

Angewandte Chemie - International Edition, 2022
Peter Seeberger, Julinton Sianturi
exaly  

[Focus on Acinetobacter baumannii].

Presse medicale (Paris, France : 1983), 2000
Acinetobacter baumannii carbapeneme-resistance is a serious problem due to the difficulty encountered in treating patients infected with this type of multiresistant bacteria. Several teams have detailed the resistance mechanisms and the way this type of strain spreads around the world.
openaire   +1 more source

[Update on Acinetobacter baumannii].

Presse medicale (Paris, France : 1983), 2003
RESISTANCE TO IMIPENEM: The increase in the prevalence of A. baumannii resistance is worrying because of the diversity of the enzymes implicated in the resistance and its epidemic diffusion that is always difficult to handle. BROAD SPECTRUM BETA-LACTAMASE: Still rare in Acinetobacter, a broad spectrum beta-lactamase has been demonstrated in a strain ...
openaire   +1 more source

Home - About - Disclaimer - Privacy